Estimation of serum mercury levels in patients taking karrupu vishnu chakara mathirai for 30 days

Profiling of serum mercury levels in patients taking karrupu vishnu chakara mathirai for 30 days- A observational study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057343

Enrollment

Registered

2023-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M258- Other specified joint disorders

Interventions

Intervention1: KARRUPU VISHNU CHAKARA MATHIRAI: 100 Mg tablet 2 BD with honey for 30 days Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18-70years 2.Sex - MALE FEMALE TRANSGENDER 3. Patients willing to participate in the study 4. Patients who are taking karrupu vishnu chakara mathirai for 30 days.

Exclusion criteria

Exclusion criteria: 1. Known case of DIABETES MELLITUS, HYPERTENSION 2. Pregnant and lactating women 3.Patients taking other mercurial compounds other than karrupu Vishnu chakara mathirai 4. patients not willing to participate in the study.

Design outcomes

Primary

Measure	Time frame
Serum mercury levels & its elimination after drug consumption will be elicited and compared with permissible limits & toxicity with respect to renal & liver parameter will be evaluated.Timepoint: 4 months - patient enrollment 2 month - outcome assessment	—

Secondary

Measure	Time frame
toxicity with respect to renal & liver parameter will be evaluated.Timepoint: 4 months - patient enrollment 2 month - outcome assessment	—

Countries

India

Contacts

Public ContactDrRMEENAKUMARI

national institute of siddha

mkumari474@yahoo.com9176534465

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026